Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D09QMX
|
|||
| Former ID |
DIB003504
|
|||
| Drug Name |
Q-301
|
|||
| Indication | Atopic dermatitis [ICD-11: EA80; ICD-10: L20; ICD-9: 691.8, 692.9] | Phase 2 | [1] | |
| Hepatitis C virus infection [ICD-11: 1E51.1; ICD-10: B18.2] | Phase 2 | [2] | ||
| Company |
Quro Science Inc
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 2 | ClinicalTrials.gov (NCT02426359) Safety and Efficacy Study of Q301 in Moderate to Severe Atopic Dermatitis Patients. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.